Industry Balks At Deadline For New Manufacturing Volume Reporting Requirements
Executive Summary
Comments cite requests for delayed or phased implementation, question how data will be used, and ask whether current reporting avenues could be used to gather similar information, among other concerns.
You may also be interested in...
The Quality Lowdown: The Latest FDA Guidance On Production Reporting, Alternate Facilities, Sources
Guidance on production reporting and on facility switching are part of the agency's new searchable quality guidance listing.
FDA Email Alert: Next Day’s Manufacturing Volume Reporting Due Date Still Voluntary
Objections to 15 February reporting date established in draft guidance spurred rare last-minute notice assuring industry that it was a non-binding recommendation, not a requirement. Action reflects confusion that can arise in interpreting policy guidance.
US Supply Chain "Elasticity" Pilot Would Get Major Funds In House-Passed Legislation
COMPETES Act also includes enhanced penalties for drug makers who falsify or destroy records, power for the FDA to recall harmful drugs, funding for drug manufacturing technology and additional supply chain flexibility efforts.